Trials / Active Not Recruiting
Active Not RecruitingNCT05825001
Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers
Pilot Study of Episodic Future Thinking Among Cigarette Smokers
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.
Detailed description
PRIMARY OBJEECTIVE: I. To evaluate the efficacy of episodic future thinking (EFT) for smoking cessation. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I (ACTIVE): Participants receive the active EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study. ARM II (CONTROL): Participants receive the control EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Smoking Cessation Intervention | Receive active EFT stimulus |
| BEHAVIORAL | Smoking Cessation Intervention (control) | Receive control EFT stimulus |
| OTHER | Medical Device Usage and Evaluation | Use iCOquit Smokerlyzer carbon monoxide monitor |
Timeline
- Start date
- 2024-09-15
- Primary completion
- 2025-10-01
- Completion
- 2026-10-01
- First posted
- 2023-04-24
- Last updated
- 2026-02-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05825001. Inclusion in this directory is not an endorsement.